G. Edward Griffin's "World Without Cancer" reveals the orchestrated suppression of a potential cure for cancer
- G. Edward Griffin, author of "World Without Cancer: The Story of Vitamin B17 Part 2," claims the cancer industry is a "farce." He argues that it prioritizes profits over cures through expensive conventional treatments while suppressing natural alternatives.
- Griffin argues that cancer stems from uncontrolled trophoblast cells, which he believes can be managed using vitamin B17 (found in apricot kernels and bitter almonds). He says vitamin B17 targets only malignant cells – though mainstream medicine dismisses this as unproven and dangerous.
- Griffin accuses Big Pharma, regulatory agencies and medical institutions of deliberately suppressing vitamin B17 to protect the lucrative cancer treatment industry, citing historical ties between medicine and corporate interests.
- Critics, including the FDA and American Cancer Society, reject laetrile as ineffective and warn of cyanide poisoning risks. However, supporters argue medical research is biased due to pharmaceutical funding, pointing to anecdotal success stories from alternative practitioners.
- The debate over vitamin B17 reflects growing public distrust in medical institutions and corporate influence. Griffin advocates for medical transparency and patient freedom, framing the issue as a battle between natural healing and systemic corruption.
For decades, the cancer industry has been a battleground of competing medical theories, financial interests and political influence. But according to G. Edward Griffin, author of "
World Without Cancer: The Story of Vitamin B17, Part 2," the real scandal isn't just about ineffective treatments. It's about an orchestrated suppression of a potential cure.
Griffin, a long-time critic of mainstream medicine, has spent nearly 60 years challenging conventional cancer paradigms. In a recent appearance on
InfoWars, he doubled down on his controversial stance, calling the cancer industry a "farce" dominated by corporate greed.
His book, first published more than 30 years ago, remains a flashpoint in alternative health circles. It presents a theory that
cancer could be largely preventable – or even curable – through nutrition, particularly the naturally occurring compound vitamin B17 (also known as amygdalin or laetrile).
Griffin's case begins with an unconventional biological perspective:
Cancer arises from uncontrolled trophoblast cells. These cells are part of the body's natural healing response to prolonged stress or damage. He argues that trophoblast cells are normally kept in check by pancreatic enzymes and vitamin B17, found in certain seeds like apricot kernels and bitter almonds.
Unlike conventional treatments such as chemotherapy, Griffin contends that B17 selectively targets malignant cells while sparing healthy ones. However, mainstream oncology rejects his claims as unproven and potentially dangerous.
The
Food and Drug Administration banned laetrile in the 1980s after studies deemed it ineffective, and the American Cancer Society classifies it as a discredited treatment. But Griffin insists the opposition is rooted in politics, not science.
The most explosive claims in "World Without Cancer" unfold in its second half. Griffin accuses Big Pharma, regulatory agencies and medical institutions of suppressing laetrile to protect profits. If cancer could be treated cheaply and naturally, he argues, it would disrupt a multibillion-dollar industry built around expensive drugs, radiation and hospital care.
He points to historical ties between the American medical establishment and corporate cartels, specifically the now-defunct IG Farben, a German chemical conglomerate with subsidiaries that later became pharmaceutical giants. These connections, Griffin alleges, evolved into a modern system where medical research and policy favor proprietary drugs over natural remedies. He asserts that each year, more people make a living from cancer than die from it – framing the issue as a battle between corporate greed and patient welfare.
Critics dismiss Griffin's arguments as conspiratorial, citing a lack of peer-reviewed evidence supporting B17's efficacy. The Mayo Clinic, National Cancer Institute and other institutions warn that laetrile can cause cyanide poisoning, and multiple studies have found no antitumor benefits.
Yet, proponents argue bias in medical research, contending that institutions funded by drug companies have little incentive to explore alternatives. Some holistic doctors and patients report anecdotal success with B17, though such claims remain outside mainstream acceptance. Frustration with high drug prices, opaque research funding and medical authoritarianism has fueled interest in independent health research.
Griffin's solution? A grassroots movement demanding medical transparency, free from "scientific arrogance and political vested interests." Whether his claims hold merit or not, his critiques tap into enduring distrust of institutions – a sentiment that continues shaping health discourse today.
The saga of vitamin B17 refuses to disappear, embodying a deeper cultural clash. Can nature provide overlooked cures, or does modern medicine’s rejection of them reflect necessary caution? Griffin's narrative of suppressed science and systemic corruption may never gain mainstream acceptance, but it raises unsettling questions about who controls medical knowledge and why.
As cancer remains a leading cause of death worldwide, the debate over amygdalin ensures that "World Without Cancer: The Story of Vitamin B17 Part 2" – and its allegations – will linger in the shadows of medical history, championed by some as a revelation and dismissed by others as a dangerous myth. One thing is certain:
The intersection of health, money and power guarantees this controversy is far from over.
Watch this video about G. Edward Griffin's book "World Without Cancer: The Story of Vitamin B17, Part 2."
This video is from the
BrightLearn channel on Brighteon.com.
Sources include:
Brighteon.ai
Brighteon.com
